In today’s biopharma landscape, microbial versatility isn’t a luxury—it’s a necessity. For decades, Escherichia coli has been the microbial workhorse of the CDMO world, offering fast growth, simple genetics, and ease of scale-up. But the biologics being made today—complex enzymes, glycosylated proteins, biosimilars, and new modalities—are pushing the limits of what E. coli can deliver. […]
Tag: Recombinant Protein Production
E. coli Innovations: Pioneering DNA Vaccines, Enzyme Fermentation & CRISPR Advances
Escherichia coli remains one of the most studied organisms in biotechnology. Recent developments showcase its versatile application in producing DNA vaccines, optimizing enzyme fermentation processes, and even enabling novel CRISPR enzyme production. This post explores the latest breakthroughs in E. coli-based technologies—from DNA vaccine trials and transcutaneous immunization strategies to leveraging bacterial sensors for CRISPR […]
